Naltrexone prevents ethanol-induced changes in rat thymus. NLM AIDSLINE Important note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Naltrexone prevents ethanol-induced changes in rat thymus.

Alcohol. 1996 Nov-Dec;13(6):533-7. Unique Identifier : AIDSLINE MED/97107198
Budec M; Leposavic G; Karapetrovic B; Kosec D; Institute for Medical Research, Beograd, Yugoslavia.


Abstract: Ethanol is known to suppress the immune response, but the underlying mechanism accounting for the immunosuppression is not clearly elucidated yet. The purpose of this study was to investigate the effect of a single dose of ethanol on relative proportion of the four major rat thymocyte subsets and possible mechanism of its action. To this end, adult female AO rats were treated with: a) ethanol (2 or 4 g/kg, i.p.), b) naltrexone (5 mg/kg, i.p.) followed 45 min later by ethanol (2 or 4 g/kg, i.p.), c) naltrexone (5 mg/kg, i.p.), or d) only saline. Twenty hours later the rats were sacrificed and the proportion of the four major thymocyte populations defined by expression of CD4 and CD8 molecules was analyzed. Flow cytometric analysis revealed that ethanol evoked a decrease in the percentage of double-positive CD4+CD8+ thymocytes followed by a proportional increase in the percentage of single-positive CD4+CD8- cells. Naltrexone pretreatment prevented the ethanol-induced alterations in thymocyte subsets. The results clearly indicate that ethanol affects the process of intrathymic T-cell maturation. It seems that this effect might be mediated by an opioid-dependent mechanism.
Keywords: *Alcohol, Ethyl/TOXICITY *Naltrexone/PHARMACOLOGY *Narcotic Antagonists/PHARMACOLOGY *T-Lymphocytes/DRUG EFFECTSKWDalcohol,ethyl/toxicityKWDnaltrexone/pharmacologyKWDnarcoticantagonists/pharmacologyKWDt-lymphocytes/drugeffects
970530
M9751987

Copyright © 1997 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .